MARKET

NAOV

NAOV

NanoVibronix Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9702
-0.0698
-6.71%
Opening 10:22 01/15 EST
OPEN
1.030
PREV CLOSE
1.040
HIGH
1.060
LOW
0.9603
VOLUME
512.17K
TURNOVER
--
52 WEEK HIGH
3.500
52 WEEK LOW
0.5351
MARKET CAP
18.73M
P/E (TTM)
-0.9770
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
iQIYI, Galapagos leads premarket losers' pack
Concord Medical Services Holdings (CCM) -40%.vTv Therapeutics (VTVT) -33% after azeliragon flunks in mid-stage alzheimer’s and diabetes study.BioLineRx (BLRX) -27% despite promising motixafortide data in pancreatic cancer.NanoVibronix (NAOV) -17%.Galapagos (GLPG) -15% after signing new commercialization pact for
Seekingalpha · 12/16/2020 13:31
NanoVibronix announces expansion of distribution pact for its ultrasound devices
NanoVibronix ([[NAOV]] +2.4%) has expanded and replaced its original distribution agreement with Ultra Pain Products ((UPPI)), which extend the term and increase minimum purchase requirements.Under the terms of the three-year
Seekingalpha · 12/11/2020 14:47
Nanovibronix Amends, Expands Distribution Agreement For PainShield, PainShield Plus
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus® Ultra Pain Products, Inc. to Distribute Company's Pain Management Devices to DME Market Under a Private Label
Benzinga · 12/11/2020 13:07
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus®
Business Wire · 12/11/2020 13:00
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield(R) and PainShield Plus(R)
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc. ("UPPI"). Under the terms of the new agreement, which extend the term and increase minimum purchase requirements, UPPI will be the exclusive distributor of privately labeled PainShield(R) and PainShield(R) Plus(TM) devices to the Durable Medical Equipment (DME) distribution sector of the healthcare market in the United States.
BusinessWire · 12/11/2020 10:00
NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements
Business Wire · 12/08/2020 13:00
NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield(R) and PainShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield and PainShield meet the New Zealand Medical Devices Safety Authority regulatory requirements and have been added to the official WAND database in accordance with the Regulations. Coupled with this approval, the company signed an agreement, and fulfilled its first shipment, with Obex Medical Ltd to distribute both of the Company's technologies throughout New Zealand.
BusinessWire · 12/08/2020 10:00
NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the closing of its previously announced private placement of 8,571,429 shares of common stock (or common stock equivalents) at a purchase price of $0.70 per share that was priced "at-the-market" under Nasdaq Rules and resulted in gross proceeds of approximately $6.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company.
Business Wire · 12/07/2020 22:10
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NAOV. Analyze the recent business situations of NanoVibronix Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NAOV stock price target is 10.50 with a high estimate of 10.50 and a low estimate of 10.50.
EPS
Institutional Holdings
Institutions: 11
Institutional Holdings: 772.01K
% Owned: 4.00%
Shares Outstanding: 19.31M
TypeInstitutionsShares
Increased
2
122.87K
New
7
14.61K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.35%
Healthcare Equipment & Supplies
-0.13%
Key Executives
Chairman/Director
Christopher Fashek
President
William Stern
Chief Executive Officer/Director
Brian Murphy
Chief Financial Officer
Stephen Brown
Other/Director
Harold Jacob
Director
Martin Goldstein
Independent Director
Michael Ferguson
Independent Director
Thomas Mika
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NAOV
NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of NanoVibronix Inc stock information, including NASDAQ:NAOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NAOV stock methods without spending real money on the virtual paper trading platform.